pioglitazone has been researched along with Cranial Nerve II Injuries in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, J | 1 |
| Zhang, J | 1 |
| Ji, M | 1 |
| Gu, H | 1 |
| Xu, Y | 1 |
| Chen, C | 1 |
| Hu, N | 1 |
1 other study available for pioglitazone and Cranial Nerve II Injuries
| Article | Year |
|---|---|
The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPARĪ³ in retinal neuroprotection.
Topics: Analysis of Variance; Anilides; Animals; Blotting, Western; Fluorescent Antibody Technique; Gene Exp | 2013 |